NIRAMAI Health Analytix vs Recursion
Which Healthcare AI tool is better in 2026?
NIRAMAI Health Analytix
A novel AI-based medical device for early, accurate, portable, and privacy-aware breast cancer detection.
Recursion
Pioneering AI-driven solutions in drug discovery to radically improve lives.
Side-by-side
Recursion is the more established option (raised $500M); pricing is comparable on both sides.
| Metric | NIRAMAI Health Analytix | Recursion |
|---|---|---|
| Taglinei | A novel AI-based medical device for early, accurate, portable, and privacy-aware breast cancer detection. | Pioneering AI-driven solutions in drug discovery to radically improve lives. |
| Foundedi | — | 2013🏆 |
| HQi | IN | Salt Lake City, US |
| Employeesi | 51-200 | 501-1000🏆 |
| Neuron scorei | 31 | 67🏆 |
| Total fundingi | Undisclosed | $500M🏆 |
| Latest roundi | — | IPO · Apr 2021 |
| Valuationi | — | $2B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✗ |
| Free triali | ✗ | ✗ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Enterprise · Contact sales | Enterprise · Contact sales |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for NIRAMAI Health Analytix and Recursion.
| Capability | NIRAMAI Health Analytix | Recursion |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✗ |
| Free trial | ✗ | ✗ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of NIRAMAI Health Analytix
- Strong in AI Healthcare
🔵 Strengths of Recursion
- Has raised more capital ($500M vs Undisclosed)
- Higher Neuron score (67 vs 31)
- Newer company (2013)
Which should you choose?
Choose Recursion if price matters most — it starts at Enterprise · Contact sales, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Recursion if you want the most established option — it has raised $500M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
NIRAMAI Health Analytix vs Recursion — which is better?
It depends on your priority. NIRAMAI Health Analytix is the leaner option; Recursion has broader feature depth. See the side-by-side table above.
Is NIRAMAI Health Analytix cheaper than Recursion?
No — Recursion's cheapest paid plan is Enterprise · Contact sales, while NIRAMAI Health Analytix's is Enterprise · Contact sales.
Do NIRAMAI Health Analytix and Recursion offer free plans?
NIRAMAI Health Analytix: Paid only. Recursion: Paid only.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.